DRI to collect details of Patanjali’s medicines
More trouble seems to be in store for yoga guru Baba Ramdev with the Directorate of Revenue Intelligence (DRI) planning to send a team of its officials to Patanjali Yogpeeth next week to collect details of certain ayurvedic medicines, recently exported by the trust.
According to sources the DRI sleuths are expected to collect documents of those medicines which have been recently manufactured for the purpose of export by the Patanjali Yogpeeth trust. The agency officials will also question some office-bearers, responsible for the export of certain ayurvedic medicines, of the trust, sources added.
“Total seven medicines, manufactured by the trust, are now under the scanner of the agency. Documents related to manufacturing of Amla Churan (manufactured by Patanjali trust) and Shilajeet Rasayan by Divya Pharmacy Yog are already being scrutinised by the DRI officials,” sources said.
The agency officials are also planning to questioning workers engaged in the manufacturing of certain ayurvedic medicines by the trusts allegedly associated with Ramdev. The DRI officials are in touch with district administration in this regard, sources added. If required the agency officials may question Ramdev and his close aide Balkrishna in this connection.
The DRI officials are scrutinising documents related to certain companies, allegedly associated with Ramdev and his aides. The companies which are under the scanner of the DRI are — Devam Ayurveda Private Ltd, Gangotri Ayurveda Ltd, Kanhal Ayurveda Private Ltd, Chaitnya Ayurveda Ltd, Aarogya Herbs (India) Pvt, Shivalic Agroherb Private Ltd, Patanjali Agro India Pvt Ltd and Patanjali Paridhan Pvt Ltd.
Meanwhile, the Enforcement Directorate (ED) is also planning to issue notice to Ramdev seeking information about his alleged investments and foreign exchange transactions made through the trusts associated with him since 2008.
Post new comment